Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity

Weinstock, 2004, Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000, Perspect Sex Reprod Health, 36, 6, 10.1363/3600604 Sutton, 2006, Prevalence of Trichomonas vaginalis in the United States, 2001-2002 Krieger, 1997, Trichomonas vaginalis and trichomoniasis, 587 Heine, 1993, Trichomonas vaginalis: a reemerging pathogen, Clin Obstet Gynecol, 36, 137, 10.1097/00003081-199303000-00019 Cates, 1999, Estimates of the incidence and prevalence of sexually transmitted diseases in the United States, Sex Transm Dis, 26, S2, 10.1097/00007435-199904001-00002 Laga, 1994, Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers, Lancet, 344, 246, 10.1016/S0140-6736(94)93005-8 McClelland, 2007, Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition, J Infect Dis, 195, 698, 10.1086/511278 2006, Sexually transmitted diseases treatment guidelines, 2006, MMWR Morb Mortal Wkly Rep, 55, 52 Nanda, 2006, Trichomoniasis and its treatment, Expert Rev Anti Infect Ther, 4, 125, 10.1586/14787210.4.1.125 Mishra, 1990, Fixed drug eruption and cross-reactivity between tinidazole and metronidazole, Int J Dermatol, 29, 740, 10.1111/j.1365-4362.1990.tb03788.x Prieto, 2005, Recurrent fixed drug eruption due to metronidazole elicited by patch test with tinidazole, Contact Dermatitis, 53, 169, 10.1111/j.0105-1873.2005.0407a.x van der Pol, 2007, Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention, Clin Infect Dis, 44, 23, 10.1086/509934 Pearlman, 1996, An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole, Am J Obstet Gynecol, 174, 934, 10.1016/S0002-9378(96)70329-0 Kurohara, 1991, Metronidazole hypersensitivity and oral desensitization, J Allergy Clin Immunol, 88, 279, 10.1016/0091-6749(91)90341-K Yu, 1993, The efficacy of povidone-iodine pessaries in a short, low-dose treatment regime on candidal, trichomonal and non-specific vaginitis, Postgrad Med J, 69, S58 Porapakkham, 1967, Metronidazole treatment of vaginal trichomoniasis, Obstet Gynecol, 29, 213 Coelho, 1997, Metronidazole resistant trichomoniasis successfully treated with paromomycin, Genitourin Med, 73, 397 Poppe, 2001, Nitroimidazole-resistant vaginal trichomoniasis treated with paromomycin, Eur J Obstet Gynecol Reprod Biol, 96, 119, 10.1016/S0301-2115(00)00403-6 Legal, 1974, The treatment of trichomonas and candida vaginitis with clotrimazole vaginal tablets, Postgrad Med J, 50, 81 Chen, 1999, Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis, Int J STD AIDS, 10, 277, 10.1258/0956462991913943 Waters, 2005, Recalcitrant Trichomonas vaginalis infection—a case series, Int J STD AIDS, 16, 505, 10.1258/0956462054308314 Nyirjesy, 1998, Difficult-to-treat trichomoniasis: results with paromomycin cream, Clin Infect Dis, 26, 986, 10.1086/513951 duBouchet, 1997, Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis, Sex Transm Dis, 24, 156, 10.1097/00007435-199703000-00006 Mammen-Tobin, 2005, Management of metronidazole-resistant Trichomonas vaginalis—a new approach, Int J STD AIDS, 16, 488, 10.1258/0956462054308422 Stern, 1967, The anti-monoamine oxidase effects of furazolidone, J Pharmacol Exp Ther, 156, 492 Narcisi, 1996, In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis, Antimicrob Agents Chemother, 40, 1121, 10.1128/AAC.40.5.1121 Schwartz, 1956, Tricofuron therapy of Trichomonas vaginitis, Obstet Gynecol, 7, 312 Walker, 1997, Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis, Int J STD AIDS, 8, 473, 10.1258/0956462971920424 Swygard, 2004, Trichomiasis: clinical manifestations, diagnosis and management, Sex Transm Infect, 80, 91, 10.1136/sti.2003.005124